Canna~Fangled Abstracts Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease. 2015 Nov 11. pii: S0091-3057(15)30095-2. doi: 10.1016/j.pbb.2015.11.006. Jayant S1, Sharma BM2, Bansal R3, Sharma B4. Author information Abstract…Freedom WaresNovember 11, 2015
